Article content

Aurora Cannabis Inc. says it can begin buying up the remaining shares of CanniMed Therapeutics Inc. after its proposed friendly takeover, valued at $1.1 billion, was approved by Canada’s anti-trust authorities.

The Edmonton-based cannabis company said Wednesday in a news release that it received a “no action” letter from the Competition Bureau, meaning its takeover of the Saskatoon-based company had cleared the final regulator hurdle.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Aurora Cannabis clears final regulatory hurdle in CanniMed acquisition Back to video

“This approval means we can move ahead with this acquisition and begin the integration of CanniMed into Aurora shortly thereafter,” Aurora CEO Terry Booth said in a statement.

Aurora and CanniMed announced the friendly takeover in late January. The deal ended a months-long hostile takeover attempt dominated by public jabs from both companies, an appeal to the provincial government and a major lawsuit, now dropped.

The larger company launched the hostile takeover bid after shareholders, including two Saskatchewan-based venture capital funds, approached it with concerns about CanniMed’s “ability … to execute,” Aurora said at the time.